Loading...
Improving Anticoagulation Management In Patients With Atrial Fibrillation
Three agents have recently been approved to reduce the risk of stroke and embolism, and one agent is in phase 3 trials. These drugs cause less serious bleeding and are simpler to manage, compared with warfarin, but they are not without their risks.
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MediMedia USA, Inc.
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3638402/ https://ncbi.nlm.nih.gov/pubmed/23641139 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|